Obesity Weight Loss Phenotypes in CKD: Findings From the Chronic Renal Insufficiency Cohort Study
- PMID: 37441488
- PMCID: PMC10334404
- DOI: 10.1016/j.ekir.2023.04.022
Obesity Weight Loss Phenotypes in CKD: Findings From the Chronic Renal Insufficiency Cohort Study
Abstract
Introduction: Although people with chronic kidney disease (CKD) and obesity have important motivations to lose weight, weight loss is also associated with health risks. We examined whether patterns of change in systolic blood pressure (SBP), serum albumin level, and fat-free mass (FFM) can help to differentiate between healthy and high-risk weight loss in this population.
Methods: Using data from the Chronic Renal Insufficiency Cohort Study (CRIC), we estimated a joint multivariate latent class model with 6 classes to identify distinct trajectories of body mass index (BMI), albumin, and SBP among participants with obesity (BMI ≥30 kg/m2 at baseline), accounting for informative missingness from death. In a secondary analysis, we fit a 6-class model with BMI and FFM.
Results: Among 2831 participants (median baseline BMI 35.6, interquartile range [IQR] 32.4-40.0 kg/m2), median follow-up was 6.8 (IQR 4.8-12.9) years, median age was 61 (IQR 54-67) years, 53% were male, 50% were non-Hispanic Black, and 82% were trying to control or lose weight at baseline. Latent classes were associated with mortality risk (5-year cumulative incidence of mortality 6.8% and 1.5% in class 6 and 3, respectively). Class 6 had the highest mortality rate and was characterized by early, steep BMI loss, early serum albumin decline, and late SBP increase. In the secondary analysis, a class characterized by steep BMI and FFM loss was associated with the highest death risk.
Conclusions: Among adults with CKD and obesity, BMI loss with concomitant serum albumin or FFM loss was associated with a high risk of death.
Keywords: nutrition; obesity; sarcopenia; weight loss.
© 2023 International Society of Nephrology. Published by Elsevier Inc.
Figures





Similar articles
-
Modification of the effects of intensive systolic blood pressure control on kidney outcomes by baseline body mass index.Nephrology (Carlton). 2021 Apr;26(4):303-311. doi: 10.1111/nep.13857. Epub 2021 Feb 23. Nephrology (Carlton). 2021. PMID: 33538091 Free PMC article. Clinical Trial.
-
Healthy lifestyle and risk of kidney disease progression, atherosclerotic events, and death in CKD: findings from the Chronic Renal Insufficiency Cohort (CRIC) Study.Am J Kidney Dis. 2015 Mar;65(3):412-24. doi: 10.1053/j.ajkd.2014.09.016. Epub 2014 Nov 20. Am J Kidney Dis. 2015. PMID: 25458663 Free PMC article.
-
Combination of low body mass index and serum albumin level is associated with chronic kidney disease progression: the chronic kidney disease-research of outcomes in treatment and epidemiology (CKD-ROUTE) study.Clin Exp Nephrol. 2017 Feb;21(1):55-62. doi: 10.1007/s10157-016-1251-2. Epub 2016 Feb 26. Clin Exp Nephrol. 2017. PMID: 26920126
-
Prehypertension, obesity, and risk of kidney disease: 20-year follow-up of the HUNT I study in Norway.Am J Kidney Dis. 2009 Oct;54(4):638-46. doi: 10.1053/j.ajkd.2009.03.023. Epub 2009 Jun 10. Am J Kidney Dis. 2009. PMID: 19515474
-
Estimated GFR Trajectories of People Entering CKD Stage 4 and Subsequent Kidney Disease Outcomes and Mortality.Am J Kidney Dis. 2016 Aug;68(2):219-228. doi: 10.1053/j.ajkd.2016.02.039. Epub 2016 Mar 4. Am J Kidney Dis. 2016. PMID: 26948835
Cited by
-
Dissecting the Obesity Paradox in Patients With Obesity and CKD.Kidney Int Rep. 2023 May 7;8(7):1281-1282. doi: 10.1016/j.ekir.2023.05.003. eCollection 2023 Jul. Kidney Int Rep. 2023. PMID: 37441481 Free PMC article. No abstract available.
-
Nonpharmacologic and Nonsurgical Weight Management Interventions for Patients With Advanced CKD: A Scoping Review of the Medical Literature.Kidney Med. 2025 Apr 15;7(6):101004. doi: 10.1016/j.xkme.2025.101004. eCollection 2025 Jun. Kidney Med. 2025. PMID: 40510614 Free PMC article. Review.
-
Impact of obesity on in-hospital outcomes in peritoneal dialysis patients: insights from a nationwide analysis.Int Urol Nephrol. 2025 Aug;57(8):2595-2601. doi: 10.1007/s11255-025-04438-w. Epub 2025 Feb 28. Int Urol Nephrol. 2025. PMID: 40021564
-
Weight change in chronic kidney disease: Association with mortality and kidney function.Obes Sci Pract. 2023 Nov 22;10(1):e723. doi: 10.1002/osp4.723. eCollection 2024 Feb. Obes Sci Pract. 2023. PMID: 38264010 Free PMC article.
References
Grants and funding
- UL1 TR002548/TR/NCATS NIH HHS/United States
- U01 DK060963/DK/NIDDK NIH HHS/United States
- UL1 RR024131/RR/NCRR NIH HHS/United States
- U01 DK061022/DK/NIDDK NIH HHS/United States
- R01 DK119199/DK/NIDDK NIH HHS/United States
- UL1 TR000003/TR/NCATS NIH HHS/United States
- UL1 TR000439/TR/NCATS NIH HHS/United States
- R01 DK124388/DK/NIDDK NIH HHS/United States
- UL1 RR029879/RR/NCRR NIH HHS/United States
- U01 DK061028/DK/NIDDK NIH HHS/United States
- UL1 TR000433/TR/NCATS NIH HHS/United States
- U01 DK060984/DK/NIDDK NIH HHS/United States
- U01 DK061021/DK/NIDDK NIH HHS/United States
- U24 DK060990/DK/NIDDK NIH HHS/United States
- U01 DK060980/DK/NIDDK NIH HHS/United States
- UL1 TR000424/TR/NCATS NIH HHS/United States
- M01 RR016500/RR/NCRR NIH HHS/United States
- P20 GM109036/GM/NIGMS NIH HHS/United States
- U01 DK060902/DK/NIDDK NIH HHS/United States
- U01 DK060990/DK/NIDDK NIH HHS/United States
- UM1 TR004528/TR/NCATS NIH HHS/United States
LinkOut - more resources
Full Text Sources